CClinicalTrials.gg
RecruitingNCT07138287Updated Aug 22, 2025

Concerned Growth Factor VS Miniral Trioide Aggregate in Treatment of Mature Permanent Teeth of Children With Symptomatic Irreversible Pulpitis.

An interventional study of Concerned Growth factor in management of Mature permanent Molar with irreversible pulpitis in Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar With Irreversible Pulpitis, sponsored by Minia University. Recruiting at 1 site in Egypt. Open to participants aged 9 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-22.

Sponsored by Minia University · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started Jul 2025; still recruiting 1 year 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Not applicable
Ages
9 Years to 16 Years
Sex
All
01

Study summary

Concerned Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar of children with irreversible pulpitis

02

Conditions studied

  • Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar With Irreversible Pulpitis
03

In context

Lead sponsor

Minia University is the lead sponsor of 356 studies on the registry; 115 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
9 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: Permanent Molar with closed Apex and diagnosed with irreversible pulpitis

-

Exclusion Criteria:

  • medically compromised children.

    • non restorable tooth
    • Necrotic tooth
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Concerned Growth factor in management of Mature permanent Molar with irreversible pulpitis

    Procedure: Concerned Growth factor in management of Mature permanent Molar with irreversible pulpitis

Interventions

  • ProcedureConcerned Growth factor in management of Mature permanent Molar with irreversible pulpitis

    Concerned Growth factor in management of Mature permanent Molar of children with irreversible pulpitis

    Also known as: Pulpotomy

06

What researchers measure

Primary outcomes

  1. Clinical evaluation of cases using visual analogue scale, electrical pulp testing, Sensibility testing using both hot and cold and Percussion test for the teeth

    Pain assessment using visual analogue scale pre operative, 6 hours post operative, 12hours post operative, 1 day post operative, 2 days post operative, 4 days, 1week, 2 weeks, 1month, 3 months, 6months and 1 year Sensibility test using thermal both hot and cold will be done pre operative and post operative Electrical pulp testing pre operative and post operative follow ups Percussion test to define any periapical or Periodontal issues

    Time frame: 12 months

  2. Radiographic evaluation of sucess of concentrated Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar with irreversible pulpitis

    Standerdized periapical x rax will be performed before treatment, 3 months, 6minths, 9 months and one year after pulpotomy in the treated teeth to evaluated radiographic sucess

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
  • Minya University Faculty of Dentistry
    Minya, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — We intend to share the data in BMC. We will share study protocol, materials and methods, results, discussion, recommendations and limitations of the current study

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07138287
Lead sponsor
Minia University
Responsible party
Ahmad Elheeny (Associate Professor of Pediatric and Community Dentistry, Minia University) — Principal investigator
First posted
Aug 22, 2025
Start date
Jul 11, 2025
Primary completion
Oct 1, 2025 (estimated)
Completion
Sep 1, 2026 (estimated)
Last update
Aug 22, 2025

Study contacts

Mahmoud Mostafa Abdelhakim, Master degree
Contact
mahmoudmostafa100001@gmail.com
201004445513

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion